Search Results - "Spronk, H. M. H."

Refine Results
  1. 1

    Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants by Spronk, Henri M H, de Jong, Anne Margreet, Crijns, Harry J, Schotten, Ulrich, Van Gelder, Isabelle C, Ten Cate, Hugo

    Published in Cardiovascular research (01-03-2014)
    “…Factor Xa and thrombin are well-known components of the coagulation cascade and have been proven to be viable targets for effective anticoagulation treatment…”
    Get full text
    Journal Article
  2. 2

    Discovery of four plasmatic biomarkers potentially predicting cardiovascular outcome in peripheral artery disease by Kremers, B. M. M., Posma, J. N., Heitmeier, S., Glunz, J., ten Cate, H., Pallares Robles, A., Daemen, J. H. C., ten Cate-Hoek, A. J., Mees, B. M. E., Spronk, H. M. H.

    Published in Scientific reports (01-11-2022)
    “…Peripheral artery disease (PAD) patients have an increased cardiovascular risk despite pharmacological treatment strategies. Biomarker research improving risk…”
    Get full text
    Journal Article
  3. 3

    Prothrombin complex concentrates and a specific antidote to dabigatran are effective ex-vivo in reversing the effects of dabigatran in an anticoagulation/liver trauma experimental model by Grottke, Oliver, van Ryn, Joanne, Spronk, Henri M H, Rossaint, Rolf

    Published in Critical care (London, England) (05-02-2014)
    “…New oral anticoagulants are effective alternatives to warfarin. However, no specific reversal agents are available for life-threatening bleeding or emergency…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Calibrated automated thrombogram II: removing barriers for thrombin generation measurements by Giesen, P. L. A, Gulpen, A. J. W, van Oerle, R, ten Cate, H, Nagy, M, Spronk, H. M. H

    Published in Thrombosis journal (28-08-2021)
    “…Abstract Background Thrombin generation (TG) assessed by Calibrated Automated Thrombogram (CAT-I) reflects the overall capacity of plasma to generate thrombin,…”
    Get full text
    Journal Article
  6. 6

    Inadequate response to antiplatelet therapy in patients with peripheral artery disease: a prospective cohort study by Kremers, B M M, Daemen, J H C, Ten Cate, H, Spronk, H M H, Mees, B M E, Ten Cate-Hoek, A J

    Published in Thrombosis journal (10-01-2023)
    “…Patients with peripheral artery disease (PAD) are treated with preventive strategies to improve the cardiovascular risk. The incidence of cardiovascular events…”
    Get full text
    Journal Article
  7. 7

    Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events by Loeffen, Rinske, van Oerle, René, Leers, Mathie P G, Kragten, Johannes A, Crijns, Harry, Spronk, Henri M H, Ten Cate, Hugo

    Published in PloS one (15-07-2016)
    “…In acute coronary syndrome (ACS) cardiac cell damage is preceded by thrombosis. Therefore, plasma coagulation markers may have additional diagnostic relevance…”
    Get full text
    Journal Article
  8. 8

    Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice by Posthuma, Jelle J., Posma, Jens J. N., van Oerle, Rene, Leenders, Peter, van Gorp, Rick H., Jaminon, Armand M. G., Mackman, Nigel, Heitmeier, Stefan, Schurgers, Leon J., ten Cate, Hugo, Spronk, Henri M. H.

    Published in Scientific reports (07-03-2019)
    “…Atherosclerosis is a progressive inflammatory vascular disorder, complicated by plaque rupture and subsequently atherothrombosis. In vitro studies indicate…”
    Get full text
    Journal Article
  9. 9

    Preanalytic variables of thrombin generation: towards a standard procedure and validation of the method by LOEFFEN, R., KLEINEGRIS, M.‐C. F., LOUBELE, S. T. B. G., PLUIJMEN, P. H. M., FENS, D., van OERLE, R., ten CATE, H., SPRONK, H. M. H.

    Published in Journal of thrombosis and haemostasis (01-12-2012)
    “…Background: Thrombin generation assays are sensitive methods for assessment of the overall clotting potential of plasma, but, despite their common use in…”
    Get full text
    Journal Article
  10. 10

    Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats by Schurgers, Leon J., Spronk, Henri M.H., Soute, Berry A.M., Schiffers, Paul M., DeMey, Jo G.R., Vermeer, Cees

    Published in Blood (01-04-2007)
    “…Arterial calcification (AC) is generally regarded as an independent risk factor for cardiovascular morbidity and mortality. Matrix Gla protein (MGP) is a…”
    Get full text
    Journal Article
  11. 11

    Composition of PM affects acute vascular inflammatory and coagulative markers - the RAPTES project by Strak, Maciej, Hoek, Gerard, Godri, Krystal J, Gosens, Ilse, Mudway, Ian S, van Oerle, René, Spronk, Henri M H, Cassee, Flemming R, Lebret, Erik, Kelly, Frank J, Harrison, Roy M, Brunekreef, Bert, Steenhof, Maaike, Janssen, Nicole A H

    Published in PloS one (13-03-2013)
    “…Exposure to ambient particulate matter (PM) has been associated with adverse cardiovascular effects in epidemiological studies. Current knowledge of…”
    Get full text
    Journal Article
  12. 12

    Prothrombin complex concentrate reduces blood loss and enhances thrombin generation in a pig model with blunt liver injury under severe hypothermia by Honickel, Markus, Rieg, Annette, Rossaint, Rolf, Braunschweig, Till, Spronk, Henri M H, ten Cate, Hugo, van Oerle, Rene, Tolba, Rene, Grottke, Oliver

    Published in Thrombosis and haemostasis (01-10-2011)
    “…Although prothrombin complex concentrate (PCC) is increasingly used for the treatment of trauma-induced coagulopathy, few studies have investigated the impact…”
    Get more information
    Journal Article
  13. 13

    Thrombin generation capacity of prothrombin complex concentrate in an in vitro dilutional model by Grottke, Oliver, Rossaint, Rolf, Henskens, Yvonne, van Oerle, Rene, Ten Cate, Hugo, Spronk, Henri M H

    Published in PloS one (17-05-2013)
    “…The use of PCC for the treatment of trauma-induced coagulopathy potentially increase the risk of thromboembolism and disseminated intravascular coagulation,…”
    Get full text
    Journal Article
  14. 14

    Integrating Mechanisms in Thrombotic Peripheral Arterial Disease by Nagy, Magdolna, van der Meijden, Paola E. J, Glunz, Julia, Schurgers, Leon, Lutgens, Esther, ten Cate, Hugo, Heitmeier, Stefan, Spronk, Henri M. H

    Published in Pharmaceuticals (Basel, Switzerland) (01-11-2022)
    “…Peripheral arterial disease (PAD), a manifestation of systemic atherosclerosis, is underdiagnosed in the general population. Despite the extensive research…”
    Get full text
    Journal Article
  15. 15

    Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution by Grottke, Oliver, van Ryn, Joanne, Zentai, Christian, Gan, Guanfa, Honickel, Markus, Rossaint, Rolf, Ten Cate, Hugo, Spronk, Henri M H

    Published in PloS one (07-01-2019)
    “…Idarucizumab is a humanized Fab fragment that specifically reverses dabigatran anticoagulation. In trauma, volume expanders are used for resuscitation to…”
    Get full text
    Journal Article
  16. 16

    Thrombin generation in the Glasgow Myocardial Infarction Study by Smid, Machiel, Dielis, Arne W J H, Spronk, Henri M H, Rumley, Ann, van Oerle, Rene, Woodward, Mark, ten Cate, Hugo, Lowe, Gordon

    Published in PloS one (24-06-2013)
    “…Thrombin is a key protease in coagulation also implicated in complex pathology including atherosclerosis. To address the role of thrombin in relation to…”
    Get full text
    Journal Article
  17. 17

    Evaluation of the analytical performance of the PC100 platelet counter by Nagy, Magdolna, Fazaeli, Sepanta, van Oerle, René, Ten Cate, Hugo, Schemmann, Marcel, Sherry, John, Kelleher, Gillian, Spronk, Henri M H

    Published in Thrombosis journal (04-05-2021)
    “…Platelet count can be altered in various diseases and treatments and measuring it may provide better insight into the expected outcome. So far, quantification…”
    Get full text
    Journal Article
  18. 18

    Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia by Spronk, Henri M H, Braunschweig, Till, Rossaint, Rolf, Wüst, Dirk C, van Oerle, Rene, Lauritzen, Brian, Tolba, Rene, Grottke, Oliver

    Published in PloS one (22-06-2015)
    “…Recombinant factor VIIa (rFVIIa) is registered for use in haemophilia with inhibitors and other rare bleeding disorders, but has also been used in various…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Biological variation in tPA-induced plasma clot lysis time by Talens, Simone, Malfliet, Joyce J M C, Rudež, Goran, Spronk, Henri M H, Janssen, Nicole A H, Meijer, Piet, Kluft, Cornelis, de Maat, Moniek P M, Rijken, Dingeman C

    Published in Thrombosis and haemostasis (01-10-2012)
    “…Hypofibrinolysis is a risk factor for venous and arterial thrombosis, and can be assessed by using a turbidimetric tPA-induced clot lysis time (CLT) assay…”
    Get more information
    Journal Article